Top news of the week: 16.12.2022.
Sibylla Biotech: how physicists met biologists to discover new drugs
The founding team behind Sibylla Biotech explains how their interdisciplinary approach can speed up drug discovery.
ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
ICON finishes the second half of 2022 with an impressive line-up of awards that commend its healthcare intelligence work and status as an employer of choice, as independently judged by ...
How biotech startups can innovate through embracing applied research
Innovation is about breaking new ground and forging new pathways to confront societal issues and solve problems.
Ginkgo Has Hired A New Head Of Biopharma To Disrupt The Gene And Cell Therapies Market
Cell therapies save lives but can cost millions of dollars because of how slow and inefficient pharma R&D is. What if cell engineering was outsourced to synbio companies like Ginkgo that ...
PM360 2022 Innovative Strategy Corporate Branded TikTok from Amgen & imre Health
Corporate Branded TikTok Amgen & imre Health Contact Person: Danielle Ernest, Corporate Affairs, Senior Manager, Social Media & Emerging Platforms Strategy, Amgen [email protected] TikTok ...
AI Proteins Expands Executive Team with Hire of Industry Veteran Wendy Dwyer as Chief Business Officer
Company moves offices and labs to Fenway biotech hub to support its pioneering approach to engineering novel proteins for drug development.BOSTON--(BUSINESS WIRE)--AI Proteins (“AIP”), the ...
BeiGene’s BRUKINSA® (zanubrutinib) Demonstrated Superior Progression-Free Survival Over IMBRUVICA® (ibrutinib) in Chronic Lymphocytic Leukemia in Late-Breaker at ASH
Final ALPINE Progression-Free Survival (PFS) results simultaneously published in The New England Journal of Medicine and presented at late-breaking session at 64th American Society of ...
Scoop: Blade Therapeutics CEO, CFO appear to depart amid 'transition' after nixed SPAC
The two top executives at Blade Therapeutics appear to no longer be with the biotech after the startup failed to merge with its SPAC partner earlier this year. The biotech’s CEO and CFO no ...